MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
Establishment Labs Holdings Book Value 2011-2026 | ESTA
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Establishment Labs Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.1 M | 18.4 M | -8.18 M | 50.7 M | 75 M | 39.6 M | 69.5 M | -5.01 M | -26.4 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | -26.4 M | 29.6 M |
Quarterly Book Value Establishment Labs Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.4 M | 22.8 M | 38.6 M | 53.1 M | 32.7 M | 45 M | 56.9 M | 18.4 M | 30.5 M | 54.9 M | -16 M | -8.18 M | 1.52 M | 15.9 M | 47.8 M | 50.7 M | 61.6 M | 68.8 M | 72.6 M | 75 M | 75 M | 75 M | 75 M | 39.6 M | 39.6 M | 39.6 M | 39.6 M | 69.5 M | 69.5 M | 69.5 M | 69.5 M | -5.01 M | -5.01 M | -5.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 75 M | -16 M | 40.7 M |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 14.07 | 0.21 % | $ 2.11 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
217 M | $ 6.86 | 3.63 % | $ 493 M |  Israel |
 |
ClearPoint Neuro
CLPT
|
25.4 M | $ 13.12 | -13.44 % | $ 355 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
129 M | $ 31.16 | -0.21 % | $ 1.43 B | USA |
 |
EDAP TMS S.A.
EDAP
|
40.9 M | $ 4.49 | -2.18 % | $ 167 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-38.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
26.9 M | $ 3.4 | -0.58 % | $ 118 M | USA |
 |
Conformis
CFMS
|
54.2 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
43.2 M | $ 24.27 | 2.1 % | $ 205 M | USA |
 |
Bio-Rad Laboratories
BIO
|
6.57 B | $ 269.99 | 0.13 % | $ 7.62 B | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 40.1 | 0.53 % | $ 5.98 K | USA |
 |
BioSig Technologies
BSGM
|
-1.42 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 74.86 | 1.87 % | $ 111 B | USA |
 |
InMode Ltd.
INMD
|
683 M | $ 14.01 | 0.32 % | $ 906 M | Israel |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
IRadimed Corporation
IRMD
|
86.8 M | $ 101.93 | 1.42 % | $ 1.29 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
CONMED Corporation
CNMD
|
1.03 B | $ 46.53 | 1.2 % | $ 1.44 B | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
249 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
1.2 B | $ 70.52 | 0.33 % | $ 3.85 B |  Britain |
 |
Cutera
CUTR
|
-172 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
48.3 B | $ 96.9 | 0.25 % | $ 125 B | USA |
 |
MiMedx Group
MDXG
|
257 M | $ 5.07 | -4.06 % | $ 749 M | USA |
 |
Delcath Systems
DCTH
|
68.7 M | $ 9.12 | -10.68 % | $ 260 M | USA |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
Dynatronics Corporation
DYNT
|
3.26 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
101 M | - | - | $ 10.2 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
189 M | $ 2.44 | -0.41 % | $ 143 M | Israel |
 |
Second Sight Medical Products
EYES
|
17.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 251.19 | 1.24 % | $ 17.7 B | USA |
 |
GBS
GBS
|
2.81 M | - | -0.57 % | $ 7.12 M | USA |
 |
Quanterix Corporation
QTRX
|
347 M | $ 6.11 | -2.86 % | $ 230 M | USA |
 |
FONAR Corporation
FONR
|
146 M | $ 18.55 | -0.19 % | $ 122 M | USA |
 |
Sintx Technologies
SINT
|
8.77 M | $ 2.9 | -1.36 % | $ 10.8 M | USA |
 |
Globus Medical
GMED
|
4.57 B | $ 95.66 | -0.58 % | $ 12.9 B | USA |